Refine by
Drug Testing Articles & Analysis
59 news found
” The models are designed for flexibility and can be tailored to accommodate specific research needs, including the ability to test various drug candidates, dietary influences, and lifestyle interventions in a controlled environment. ...
Yang, L., et al (2024) introduces LungVis 1.0, an AI-driven imaging platform integrating light sheet fluorescence microscopy (LSFM) and deep learning for mapping nanoparticle (NP) deposition across murine lungs. The research highlights the advantages of aerosol-based delivery methods over traditional liquid-based approaches, emphasizing the uniformity of NP deposition in distal alveolar ...
In addition to a variety of experimental animals including mice, rats, rabbits, and monkeys, Ace Therapeutics can assist worldwide clients in constructing custom animal models using techniques such as environmental enrichment, gene editing, dietary modifications, or drug therapies. Moreover, the company can also provide researchers with cardiac organoid models and human induced ...
Developing effective treatments for IPF has been a challenge for the medical community, as the mechanisms driving this disease are complex and not fully understood. To accelerate drug discovery, animal models that closely mimic the human disease are crucial. In this context, a recent study by Petersen et al (2024) has made significant strides in validating a well-known IPF mouse ...
About CD Formulation Over the past years, CD Formulation has been strengthening its innovation in drug formulation and analytical testing, hoping to bring advancement for the pharmaceutical industry and also hoping to improve patient care on a global scale. ...
This new development has the potential to revolutionize the way oral medications are tested and administered, leading to more precise and effective treatments for a wide range of medical conditions. ...
This comprehensive range, featuring tailored bio-inks for specific applications, paves the way for revolutionary advancements in regenerative medicine, drug discovery, and beyond. Bio-ink is a material used in the 3D bioprinting industry to create structures that can imitate natural tissues and organs. ...
ByMatexcel
CD Formulation, a leading provider of innovative drug delivery solutions, has recognized the critical importance of performance testing to ensure the efficiency and safety of microneedles. ...
Working with patient-derived biopsies, immune cells and cancer stem cells to develop 3D bioprinted Micro-Tumors, Carcinotech has been providing the pharmaceutical sector with crucial services in assisting researchers to optimize drug testing workflows. The protocols on the BIO CELLX will leverage cell line based 3D models and will greatly accelerate research ...
ByCELLINK
CD Formulation’s cGMP-compliant laboratory is well-equipped to identify both the chemical and structural composition of each drug substance. More recently, the company announced to broaden its service range to tablet fragility test, dissolution test, and disintegration test. ...
Equipped with a cGMP-compliant laboratory and state-of-the-art analytical instruments, CD Formulation’s seasoned research team is well-prepared to handle the most complicated drug analytical issues as a contract service organization. The samples to be tested and analyzed could be in the form of solids, semi-solids, liquids, or gases. ...
Therefore, HLA typing is essential to the research of immune-related diseases, the screening of vaccine and drug target populations, the study of ethnic evolution, tissue, organ transplantations, etc. ...
BioMark intends to use this funding to support research and development of a quantitative assay to measure drug metabolites for cancer treatment monitoring. The project is leveraging the fully integrated BioMark’s metabolomic liquid biopsy platform to develop a safe, effective, and affordable drug biomarker test to assess and monitor ...
” “We are proud to have received the NSF-SBIR grant and look forward to continuing to successfully predict complex, ideal drug combinations to assess drug efficacy and toxicity in treating COVID-19. ...
Molecular Devices, LLC., a leading provider of high-performance life science solutions, today announced the acquisition of Cellesce Ltd (“Cellesce”) which specializes in contract development and manufacturing of large scale patient-derived organoids (PDOs) for diverse applications, including drug screening. Drug efficacy and toxicity ...
TissUse will receive funding from the Bill & Melinda Gates Foundation to develop a human preclinical lung-liver-lymph node co-culture on a HUMIMIC Chip infectable with Mycobacterium tuberculosis. This collaboration will contribute to the development of Tuberculosis vaccine candidates and treatment modalities. TissUse announced today that it has received funding from the Bill & Melinda ...
These results solve the critical issue of CTC rarity and pave the way for their use in early diagnostics of cancer, prognostics, theranostics, and in vitro personalized drug efficacy tests, including through CTC culture. “With the ISET technology, we were able to effectively extract CTC in higher numbers and from larger DLA volumes, in all cases thus ...
Human induced pluripotent stem cell-derived beta-cells for drug and toxicity ...
As a spin-out from the Fred Hutchinson Cancer Research Center, SEngine is leveraging decades of R&D experience in drug discovery and diagnostics. SEngine’s PARIS® Test platform underpins a unique functional technology approach to drug discovery driving our assets against novel synthetic lethal drug targets. ...
Additionally, data from the PARIS Test is used to accelerate drug discovery by identifying optimal patient populations for specific drugs. About SEngine Precision Medicine SEngine Precision Medicine Inc. is revolutionizing cancer therapies by pre-testing drugs on patient-derived 3D tumor models and engaging in ...